Intra-cellular Therapies, Inc. (ITCI) Earnings
|
Expand Research on ITCI
| Next EPS Date | 5/8/24 | EPS Growth Rate | +28.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +34.3% | Revenue Growth Rate | +47.0% |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/1/22 |  |
Q421 | -$1.05 | -$1.00 | -$0.05 | $25.7M | $25.37M | N/A |  | | Details |
| 11/9/20 | |
Q320 | -$0.79 | -$1.00 | +$0.21 | $7.37M | $5.86M | N/A | | | Details |
| 5/7/20 | |
Q120 | -$0.73 | -$0.93 | +$0.20 | $1.08M | $1.44M | N/A | | | Details |
| 5/10/22 | |
Q122 | -$0.78 | -$0.92 | +$0.14 | $35M | $33.65M | N/A | | | Details |
| 2/27/19 | |
Q418 | -$0.75 | -$0.91 | +$0.16 | N/A | N/A | N/A | | | Details |
| 8/10/20 | |
Q220 | -$0.96 | -$0.91 | -$0.05 | $1.91M | $3.03M | N/A | | | Details |
2/25/16  |
|
Q415 | -$0.67 | -$0.90 | +$0.23 | $30.66M | $60K | N/A | | | Details |
| 11/9/21 | |
Q321 | -$0.95 | -$0.89 | -$0.06 | $22.2M | $22.25M | N/A | | | Details |
